Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Stephen Taub
Latest Articles
Premium
Life Sciences Venture Investments Still Have a Pulse
Stephen Taub
March 24, 2022
Premium
Third Point Trims SentinelOne, Its Largest Long
Stephen Taub
March 23, 2022
Premium
Hedge Funds Gear Up for a Rare IPO
Stephen Taub
March 22, 2022
Premium
Anaplan Activists Are Quickly Rewarded
Stephen Taub
March 21, 2022
Premium
Are Tiger Funds Losing Their Appetite for Private Markets?
Stephen Taub
March 18, 2022
Premium
What’s Next for Russia-Focused Hedge Funds?
Stephen Taub
March 17, 2022
Premium
Troubling Times for Ginkgo Bioworks
Stephen Taub
March 16, 2022
Premium
Online Grocer Instacart, a Tiger Fund Favorite, Takes a Valuation Hit
Stephen Taub
March 15, 2022
Premium
Tiger Global Changes Up Its Private Market Strategy
Stephen Taub
March 14, 2022
The Richest Rich List: The 21st Annual Ranking of the Highest-Earning Hedge Fund Manager's
Sponsored by
XLR8
March 10, 2022
Premium
Maverick’s Roller Coaster Ride
Stephen Taub
March 9, 2022
Premium
Third Point Goes Activist on Cano Health
Stephen Taub
March 9, 2022
Premium
In a Down Market, Valiant Plays the Long Game
Stephen Taub
March 8, 2022
Premium
Impala Starts the Year With Big Gains
Stephen Taub
March 7, 2022
Premium
Third Point Extends Its Losing Streak
Stephen Taub
March 7, 2022
Premium
Haidar Continues to Kill It
Stephen Taub
March 4, 2022
Premium
Glenview Gets Off to a Strong Start
Stephen Taub
March 2, 2022
Premium
Another Disappointing Year for Carl Icahn
Stephen Taub
March 1, 2022
More Articles